These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 772233)
21. Progress of the control of urinary schistosomiasis among school-children in Iraq by selective mass treatment campaign with etrenol in the last four school years (1973 - 1974 - 1976 - 1977). Baquir H Bull Endem Dis (Baghdad); 1978 Nov; 19(1-4):77-86. PubMed ID: 757132 [No Abstract] [Full Text] [Related]
22. [Electrocardiographic changes in patients with schistosomiasis mansoni treated with hycanthone]. Takaoka L; Baldy JL; Passos JD; Soares EC; Zeitune JM; Siqueira JE Rev Inst Med Trop Sao Paulo; 1976; 18(5):378-86. PubMed ID: 1006067 [No Abstract] [Full Text] [Related]
24. The treatment of schistosomiasis mansoni in Murang'a District, Kenya: a double blind controlled trial of three hycanthone regimens and oxamniquine. Rees PH; Bowry HN; Roberts JM; Thuku JJ Am J Trop Med Hyg; 1975 Sep; 24(5):823-6. PubMed ID: 1190368 [No Abstract] [Full Text] [Related]
25. Serum immunoglobulin concentrations in human S. mansoni and S. haematobium infections in the Sudan, with special reference to the effect of chemotherapy. Salih SY; Voller A; Woodruff AW Tropenmed Parasitol; 1978 Sep; 29(3):269-74. PubMed ID: 726042 [TBL] [Abstract][Full Text] [Related]
26. Hycanthone in experimental schistosomiasis studies on liver pathology in mice treated with one and two doses. Farag HF; Guirguis RS; Sherif A; Hanna AT J Egypt Med Assoc; 1976; 59(5-6):439-47. PubMed ID: 1032313 [No Abstract] [Full Text] [Related]
27. The effect of a second dose of hycanthone alone and with progesterone caproate on the cure rate and the side reactions of hycanthone in the treatment of S. haematobium infected cases. El-Abdin AZ; Samy G; Mousa AH; El-Raziky EH; Roshdy MZ; Abd-El-Rahman H; Hafez S; Adham IA Egypt J Bilharz; 1974; 1(1):117-33. PubMed ID: 4619883 [No Abstract] [Full Text] [Related]
28. [Resistance to hycanthone and oxamniquine in patients with a clinical hepato-intestinal form of schistosomiasis]. Guimarães RX; Tchakerian A; Dias LC; de Almeida FM; Vilela MP; Cabeca M; Takeda AK AMB Rev Assoc Med Bras; 1979 Feb; 25(2):48-50. PubMed ID: 314642 [No Abstract] [Full Text] [Related]
29. Hycanthone methanesulfonate (etrenol) in the treatment of S. mansoni. Ongom VL East Afr Med J; 1971 Jun; 48(6):247-50. PubMed ID: 5136919 [No Abstract] [Full Text] [Related]
30. Serum enzymatic changes in patients with schistosomiasis treated with oxamniquine or hycanthone. Comparative study. Saéz-Alquézar A; Ohtsuki N; Sette Júnior H; Magnanelli AC; Raia S; da Silva LC Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):105-10, 225-31. PubMed ID: 7455503 [No Abstract] [Full Text] [Related]
31. An assessment of anti-schistosomal treatment on physical work capacity. Awad El Karim MA; Collins KJ; Sukkar MY; Omer AH; Amin MA; Doré C J Trop Med Hyg; 1981 Apr; 84(2):67-72. PubMed ID: 7218405 [TBL] [Abstract][Full Text] [Related]
32. Hycanthone: a review of its experimental chemotherapy, pharmacology and toxicology. Farah A; Berberian DA; Davison C; Dennis EW; Donikian MA; Drobeck HP; Ferrari RA; Yarinsky A Egypt J Bilharz; 1974; 1(2):181-95. PubMed ID: 4220100 [No Abstract] [Full Text] [Related]
33. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni. Haese WH; Bueding E J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276 [TBL] [Abstract][Full Text] [Related]
34. Serology of Schistosoma mansoni infections after chemotherapy. Doenhoff MJ; Dunne DW; Lillywhite JE Trans R Soc Trop Med Hyg; 1989; 83(2):237-8. PubMed ID: 2514476 [No Abstract] [Full Text] [Related]
35. Curative chemotherapy and resistance to reinfection in murine schistosomiasis. Andrade ZA; Azevedo de Brito P Am J Trop Med Hyg; 1982 Jan; 31(1):116-21. PubMed ID: 7058973 [TBL] [Abstract][Full Text] [Related]
36. Biochemical studies on beta-glucuronidase enzyme in liver and spleen homogenates of normal and Schistosoma mansoni infected mice treated with hycanthone. Saad AA; el-Zoghby SM; el-Sewedy SM; Girgis LH; Farag HF; Moghazy M Biochem Pharmacol; 1978 Feb; 27(4):473-4. PubMed ID: 629806 [No Abstract] [Full Text] [Related]
37. Hycanthone dose-response in Schistosoma mansoni infection in Kenya. Warren KS; Siongok TK; Ouma JH; Houser HB Lancet; 1978 Feb; 1(8060):352-4. PubMed ID: 75394 [TBL] [Abstract][Full Text] [Related]
38. Control of Schistosoma mansoni transmission by chemotherapy in St. Lucia. I. Results in man. Cook JA; Jordan P; Bartholomew RK Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):887-93. PubMed ID: 907051 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic evaluation of hycanthone in school children in rural endemic area in Egypt. Mousa AH; El-Abdin AZ; El-Garem AA; El-Raziky EH; Fadl AA Egypt J Bilharz; 1974; 1(1):65-83. PubMed ID: 4469236 [No Abstract] [Full Text] [Related]
40. A comparison of oral and parenteral activity of hycanthone and lucanthone in experimental infections with Schistosoma mansoni. Berberian DA; Freele H; Rosi D; Dennis EW; Archer S Am J Trop Med Hyg; 1967 Jul; 16(4):487-91. PubMed ID: 5006468 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]